What should be the management of patients with NSTE-ACS following noncardiac surgery?
Patients with NSTE-ACS following noncardiac surgery should be managed according to the guidelines for patients in the general population, with risk stratification and guideline-based pharmacological and invasive management directed at the etiology (eg, hypertension, tachycardia, HF, hypotension, sepsis, and anemia) with modifications based on the severity of NSTE-ACS and the limitations imposed by the noncardiac surgical procedure. The definition of ACS has a substantial effect on reported Some patients may not be able to give a history of ischemic symptoms because of the noncardiac surgery. The criteria in the 2012 Third Universal Definition of MI should be applied. In patients at risk of ACS following non-cardiac surgery, routine monitoring of troponins and ECGs may be performed. As the sensitivity of troponin assays improves, the frequency of identifying perioperative MI will increase.